Cho Alice S
Known title: DirectorCIK: 0001812520
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Globe Life (GL) Seen as Discounted with Strong Dividends and Buybacks. Analysts highlighted Globe Life’s discounted valuation, noting a trailing P/E of about 10.5 and a dividend that is increasing. The reports also point to aggressive share buybacks and solid fundamentals that may help the company outperform its financial‑services peers. Some commentary mentions low‑volatility characteristics but raises questions about the strength of those fundamentals.
Transaction History
| FIBK | ▲ Buy | Grant | 2,247 | $0 | 6/1/2026 | View on chart |
| GL | ▲ Buy | Grant | 1,373 | $0 | 1/2/2026 | View on chart |
| FIBK | ▲ Buy | Grant | 2,946 | $0 | 6/1/2025 | View on chart |
| GL | ▲ Buy | Grant | 1,604 | $0 | 1/2/2025 | View on chart |
| FIBK | ▲ Buy | Grant | 3,014 | $0 | 6/1/2024 | View on chart |
| GL | ▲ Buy | Grant | 1,475 | $0 | 1/2/2024 | View on chart |
| FIBK | ▲ Buy | Grant | 3,401 | $0 | 6/1/2023 | View on chart |
| GL | ▲ Buy | Grant | 1,352 | $0 | 3/15/2023 | View on chart |
| FIBK | ▲ Buy | Grant | 1,576 | $60K | 6/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
FIBK Earnings Due Next Week Amid Valuation Debate
First Interstate BancSystem is set to report earnings next week, with analysts anticipating growth. Recent commentary suggests the stock may be undervalued based on excess returns, though questions remain if the current recovery is already priced in. The company trades near its 52-week low, with a dividend yield of 7.76% and an average analyst target of $37.00.
FIBK Earnings Due Next Week Amid Valuation Debate. First Interstate BancSystem is set to report earnings next week, with analysts anticipating growth. Recent commentary suggests the stock may be undervalued based on excess returns, though questions remain if the current recovery is already priced in. The company trades near its 52-week low, with a dividend yield of 7.76% and an average analyst target of $37.00.